Liminatus Pharma, Inc. (LIMN)

NASDAQ: LIMN · Real-Time Price · USD

3.680

-0.020 (-0.54%)

Sep 4, 2026, 10:31 AM EDT - Market open

Liminatus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5	17	80	75	349	337
Market Cap Growth	-92.99%	-79.39%	6.12%	-78.38%	3.48%	-
Enterprise Value	3	17	97	89	-	-
Last Close Price	3.70	30.50	561.00	516.50	506.00	489.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	13.78	-1.68	-4.14	-4.78	-32.30	-29.64

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	4.80	-0.15	-1.03	-1.02	-1.53	-1.16
Net Debt / Equity Ratio	-5.24	-0.11	-1.03	-0.99	-1.06	-1.16
Net Debt / EBITDA Ratio	0.39	-0.37	-	-	-4.23	-3.30
Net Debt / FCF Ratio	0.40	-0.11	-13.73	-4.67	-13.18	-78.47
Quick Ratio	0.99	0.03	0.00	0.03	0.29	0.00
Current Ratio	1.12	0.05	0.21	0.12	0.39	0.19
Return on Assets (ROA)	-95.65%	-62.65%	-54.41%	-66.30%	-35.51%	-
Return on Capital Employed (ROCE)	-1119.00%	30.30%	17.20%	30.50%	25.10%	35.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-251.98%	-61.82%	-4.43%	-6.60%	-0.84%	-1.66%
FCF Yield	-80.20%	-60.43%	-1.81%	-4.43%	-0.25%	-0.05%
Buyback Yield / Dilution	-82.95%	-35.73%	82.93%	-188.25%	-	-

SEC Filings: 10-K · 10-Q